HY26 · Released 23 February 2026
CVT swings to NZ$4.6m NPAT on 18.3% revenue surge and inventory halved
Revenue momentum is real, but a 43% inventory drawdown and minimal capex raise questions about second-half supply and growth sustainability.
CVT · NZX
Comvita is an NZX-listed consumer staples company covered by Annolyse across HY26. This page brings together the latest briefing, the current metrics snapshot, and the published history to date in one place.
Snapshot
HY26, released 23 February 2026
| Metric | Value |
|---|---|
| Revenue | $118.0m |
| Operating profit | $7.7m |
| NPAT | $4.6m |
| Operating cash flow | $20.8m |
| OCF / Operating profit % | 269.8% |
| Net debt | $48.7m |
| Net debt / Operating profit | 6.33x |
| ROE % | 7.9% |
| PBT | $4.3m |
| FCF pre-lease | $20.3m |
Longitudinal view
Current-period values from each published briefing, with the most recent reporting period shown first.
| Metric | HY266 MONTHS23 February 2026 |
|---|---|
| Revenue | $118.0m |
| Revenue growth % | 18.3% |
| Operating profit | $7.7m |
| Operating profit margin % | 6.5% |
| PBT | $4.3m |
| PBT growth % | 18.3% |
| NPAT | $4.6m |
| Operating cash flow | $20.8m |
| OCF / Operating profit % | 269.8% |
| FCF pre-lease | $20.3m |
| ROE % | 7.9% |
| Net debt | $48.7m |
| Net debt / Operating profit | 6.33x |
| Debtor days | 51 |
| Inventory days | 106 |
| Total assets | $164.4m |
Source: annolyse.ai/companies/cvt
Accountability
Read the prior briefing's expectations and unresolved questions alongside the subsequent result, without forcing long-form editorial text into narrow cards.
Once a second briefing exists for this company, this section will compare the previous briefing's expectations and unresolved issues with what actually happened in the next result.
Archive
Every published Annolyse briefing for this company appears here in reverse chronological order.
Subscribe
Subscribe to get future Annolyse briefings as soon as they are published.